1. Home
  2. EVO vs EVAC Comparison

EVO vs EVAC Comparison

Compare EVO & EVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evotec SE

EVO

Evotec SE

N/A

Current Price

$1.59

Market Cap

568.6M

Sector

Health Care

ML Signal

N/A

EVAC

EQV Ventures Acquisition Corp. II Class A Ordinary Shares

N/A

Current Price

$10.37

Market Cap

592.7M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
EVO
EVAC
Founded
1993
2024
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Fluid Controls
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
568.6M
592.7M
IPO Year
2007
2025

Fundamental Metrics

Financial Performance
Metric
EVO
EVAC
Price
$1.59
$10.37
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $4.48
N/A
AVG Volume (30 Days)
65.9K
★ 152.9K
Earning Date
11-05-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$18.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.33
$9.98
52 Week High
$3.87
$10.40

Technical Indicators

Market Signals
Indicator
EVO
EVAC
Relative Strength Index (RSI) 48.34 58.14
Support Level $1.50 $10.34
Resistance Level $1.61 N/A
Average True Range (ATR) 0.06 0.02
MACD 0.01 -0.00
Stochastic Oscillator 28.13 38.46

Price Performance

Historical Comparison
EVO
EVAC

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

About EVAC EQV Ventures Acquisition Corp. II Class A Ordinary Shares

EQV Ventures Acquisition Corp II is a blank check company.

Share on Social Networks: